Alcohol-related deaths and hospitalizations in Canada surged during the COVID-19 pandemic

The FDA’s Pul­monary-Al­ler­gy Drugs Ad­vi­so­ry Com­mit­tee vot­ed 12 to 1 in sup­port of re­ject­ing Mer­ck’s ap­pli­ca­tion for its chron­ic cough drug gefapix­ant, fol­low­ing agency con­cerns

VML Health is team­ing up with a da­ta and an­a­lyt­ics provider to stream­line and con­sol­i­date key opin­ion leader (KOL) man­age­ment. By pair­ing its ex­ist­ing KOL